Skip to content

Study · In vitro (cells) · 2006

1 result

Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions.

Gatti S, Carlin A, Sordi A, Leonardi P, Colombo G, Fassati LR, Lipton JM, Catania A

The Journal of surgical research18 Jan 2006Cited by 10 (Europe PMC)

PMID16413580 (opens in a new tab)DOI10.1016/j.jss.2005.08.009 (opens in a new tab)PepBankPUB-16413580
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In LPS-stimulated human PBMC, KPV was less potent than the dimer (CKPV)2 in inhibiting TNF-alpha production.

    In plain wordsIn human blood cells in the lab, single KPV lowered TNF-alpha less strongly than the KPV dimer (CKPV)2.

    Peptide
    KPV
    Outcome
    Not applicableTNF-alpha inhibition potency compared with KPV
    Study

    humann: not reported in source

    Peripheral blood mononuclear cells stimulated with LPS
    Comparator
    (CKPV)2
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    more potent than KPV.
    1 context sentence
    Summary · context
    (CKPV)2 inhibited TNF-alpha production by LPS-stimulated human PBMC.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 5 to 19Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 15 times, first on 13 Oct 2026, 21:44 UTC. The status did not change between them.

    Study results updated

  2. Version 4

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 3

    9 Oct 2026, 18:17 UTC

    Study results updated

  4. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  5. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.